UPSC Articles
Sputnik Light vaccine
Part of: Prelims and GS-II Health
Context: The drug regulator DCGI (Drugs Controller General of India) has granted emergency use authorisation (EUA) to Single-dose Sputnik Light COVID-19 vaccine in India.
About the vaccine
- Sputnik Light is based on recombinant human adenovirus serotype number 26 (the first component of Sputnik V).
- It is the world’s first registered combination vector vaccine for the prevention of COVID-19
- As per the vaccine developer Russian Direct Investment Fund (RDIF), a one-shot vaccination regimen of Sputnik Light provides for ease of administration and helps to increase the efficacy and duration of other vaccines when used as a booster shot.
Emergency Use Authorization (EUA)
- It is a regulatory mechanism to allow the use of vaccines and medicines to prevent and/or reduce the impact of life- threatening diseases or conditions as caused by COVID-19.
About Drugs Controller General of India
- S/he is the head of department of the Central Drugs Standard Control Organization (CDSO) of the Government of India.
- Central Drugs Standard Control Organisation works in close collaboration with the state control administration and assist them in securing uniform enforcement of the Drug Act.
- Responsible for approval of licences of specified categories of drugs such as blood and blood products, IV fluids, vaccines, and sera in India.
- DCGI also sets standards for manufacturing, sales, import, and distribution of drugs in India.
- Comes under the Ministry of Health & Family Welfare.
News Source: Livemint
